InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by LEVIN MARK J, Director. Insider active across 1 company, notably Fulcrum Therapeutics, Inc.. Aggregated, 4 disclosures have been logged. Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations
Mark J. Levin is a Board Member at Fulcrum Therapeutics, Inc. He participates in the governance of the company and strategic decision-making. Mark brings expertise in biotechnology, contributing to innovation and growth at Fulcrum.